As of early September 2026, the CDC has confirmed 3,134 measles cases across 47 jurisdictions, already surpassing the 2,289 cases recorded for all of 2025 and marking the highest annual total since 1991. Primary drivers include 38 ongoing or recent outbreaks, with 95% of cases outbreak-associated and 94% occurring in unvaccinated individuals or those with unknown status; major clusters persist in South Carolina, Pennsylvania, and Utah. Measles' high transmissibility (basic reproduction number typically 12–18) sustains chains in communities with declining MMR coverage since the pandemic. CDC weekly surveillance updates and state health reports will continue to shape final 2026 totals through year-end, with resolution depending on outbreak containment before winter respiratory season peaks.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti nel 2026?
Casi di morbillo negli Stati Uniti nel 2026?
$7,894,898 Vol.
$7,894,898 Vol.
31 dic 2026
↑3,5k
100%
↑4k
96%
↑4,5k
87%
↑4,5k
84%
↑5k
68%
↑7,5k
15%
↑10k
7%
↑12,5k
2%
$7,894,898 Vol.
$7,894,898 Vol.
31 dic 2026
↑3,5k
$15,502 Vol.
100%
↑4k
$240,759 Vol.
96%
↑4,5k
$2,485 Vol.
87%
↑4,5k
$580 Vol.
84%
↑5k
$241,164 Vol.
68%
↑7,5k
$193,412 Vol.
15%
↑10k
$6,524,515 Vol.
7%
↑12,5k
$356,524 Vol.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the CDC has confirmed 3,134 measles cases across 47 jurisdictions, already surpassing the 2,289 cases recorded for all of 2025 and marking the highest annual total since 1991. Primary drivers include 38 ongoing or recent outbreaks, with 95% of cases outbreak-associated and 94% occurring in unvaccinated individuals or those with unknown status; major clusters persist in South Carolina, Pennsylvania, and Utah. Measles' high transmissibility (basic reproduction number typically 12–18) sustains chains in communities with declining MMR coverage since the pandemic. CDC weekly surveillance updates and state health reports will continue to shape final 2026 totals through year-end, with resolution depending on outbreak containment before winter respiratory season peaks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Jun 30, 2026, 2:17 PM ET
Volume
$7,894,898Data di fine
1 gen 2027Mercato aperto
Jun 30, 2026, 2:17 PM ETRisolutore
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the CDC has confirmed 3,134 measles cases across 47 jurisdictions, already surpassing the 2,289 cases recorded for all of 2025 and marking the highest annual total since 1991. Primary drivers include 38 ongoing or recent outbreaks, with 95% of cases outbreak-associated and 94% occurring in unvaccinated individuals or those with unknown status; major clusters persist in South Carolina, Pennsylvania, and Utah. Measles' high transmissibility (basic reproduction number typically 12–18) sustains chains in communities with declining MMR coverage since the pandemic. CDC weekly surveillance updates and state health reports will continue to shape final 2026 totals through year-end, with resolution depending on outbreak containment before winter respiratory season peaks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,894,898Data di fine
1 gen 2027Mercato aperto
Jun 30, 2026, 2:17 PM ETRisolutore
0x65070BE91...As of early September 2026, the CDC has confirmed 3,134 measles cases across 47 jurisdictions, already surpassing the 2,289 cases recorded for all of 2025 and marking the highest annual total since 1991. Primary drivers include 38 ongoing or recent outbreaks, with 95% of cases outbreak-associated and 94% occurring in unvaccinated individuals or those with unknown status; major clusters persist in South Carolina, Pennsylvania, and Utah. Measles' high transmissibility (basic reproduction number typically 12–18) sustains chains in communities with declining MMR coverage since the pandemic. CDC weekly surveillance updates and state health reports will continue to shape final 2026 totals through year-end, with resolution depending on outbreak containment before winter respiratory season peaks.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti